Boron Neutron Capture Therapy of Intracerebral Melanoma Using Boronophenylalanine as a Capture Agent1

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Brain metastasis from melanoma

  2004cited by this paper
• Boron neutron capture therapy for cancer. Realities and prospects

  1992cited by this paper
• Boron neutron capture therapy for murine malignant gliomas.

  1992cited by this paper
• A Rat Model for the Treatment of Melanoma Metastatic to the Brain by Means of Neutron Capture Therapy

  1992cited by this paper
• Control of intracerebral gliosarcomas in rats by boron neutron capture therapy with p-boronophenylalanine.

  1992cited by this paper
• Advances in the Control of Human Cutaneous Primary and Metastatic Melanoma by Thermal Neutron Capture Therapy

  1992cited by this paper
• Boron neutron capture therapy of a murine melanoma with p-boronophenylalanine: dose-response analysis using a morbidity index.

  1991cited by this paper
• Determination of boron in tissues and cells using direct-current plasma atomic emission spectroscopy.

  1991cited by this paper
• Clinical results of boron neutron capture therapy.

  1990cited by this paper
• Selective delivery of boron by the melanin precursor analogue p-boronophenylalanine to tumors other than melanoma.

  1990cited by this paper
• In vitro determination of uptake, retention, distribution, biological efficacy, and toxicity of boronated compounds for neutron capture therapy: a comparison of porphyrins with sulfhydryl boron hydrides.

  1990cited by this paper
• Boron neutron capture therapy of a rat glioma.

  1990cited by this paper
• Neutron Beam Design, Development, and Performance for Neutron Capture Therapy

  1990cited by this paper
• Boron neutron capture therapy of intracerebral rat gliosarcomas.

  1990cited by this paper
• Relapse in the central nervous system in melanoma patients successfully treated with biomodulators.

  1989cited by this paper
• Acute and subacute toxicity of 10B-paraboronophenylalanine.

  1989cited by this paper
• New thermal neutron capture therapy for malignant melanoma: melanogenesis-seeking 10B molecule-melanoma cell interaction from in vitro to first clinical trial.

  1989cited by this paper
• Optimization of boron and neutron delivery for neutron capture therapy.

  1989cited by this paper
• Time- and dose-related changes in the white matter of the rat brain after single doses of X rays.

  1988cited by this paper
• Metastatic patterns in autopsy cases of cutaneous melanoma.

  1988cited by this paper
• Boron neutron capture therapy of a murine melanoma.

  1988cited by this paper
• Malignant melanoma brain me-tastases

  1985cited by this paper
• The relative biological effectiveness in V79 Chinese hamster cells of the neutron capture reactions in boron and nitrogen.

  1984cited by this paper
• Patterned Distribution of Métastases from Malignant Melanoma in Humans1

  1983cited by this paper
• Analytical calculation of boron- 10 dosage in cell nucleus for neutron capture therapy.

  1982cited by this paper
• NEUROPATHOLOGIC STUDY OF FOURTEEN CASES OF MALIGNANT BRAIN TUMOR TREATED BY BORON‐10 SLOW NEUTRON CAPTURE RADIATION

  1972cited by this paper
• The nature of latent cerebral irradiation damage and its modification by hypertension.

  1970cited by this paper

• No citing papers are available for this paper.